Adaptation and validation of the Italian Singing Voice Handicap Index-10 (SVHI-10-IT).


Journal

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
ISSN: 1827-675X
Titre abrégé: Acta Otorhinolaryngol Ital
Pays: Italy
ID NLM: 8213019

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 23 09 2022
accepted: 24 10 2022
medline: 28 4 2023
pubmed: 26 4 2023
entrez: 26 4 2023
Statut: ppublish

Résumé

The aim of this study was to adapt and validate the Italian version of the singing Voice Handicap Index-10 (SVHI-10-IT). 99 Italian singers were enrolled in the study. All subjects underwent videolaryngostroboscopic examination and were asked to fill out the self-reported 10-item SVHI-10-IT. Laryngostroboscopic examination was pathological in 56 subjects (study group) (56.6%), while it was normal in the remaining 43 singers (control group) (43.4%). Dimensionality, test retest and internal validity for SVHI-10-IT were performed. Videolaryngostroboscopy was used as gold-standard for external validity. The items of SVHI-10-IT were uni-dimensional and Cronbach's The SVHI-10-IT is a reliable and valid instrument to evaluate the self-reported singing voice handicap among singers. It can also be used as a quick screening tool since a score higher than 12 is indicative of a problematic voice as perceived by singers. Adattamento e validazione in italiano del Singing Voice Handicap Index-10 (SVHI-10-IT). Questo studio riporta il processo di validazione in lingua italiana del Singing Voice Handicap Index-10 (SVHI-10-IT). 99 cantanti italiani hanno compilato il SVHI-10-IT dopo essere stati sottoposti a laringostroboscopia, utilizzata come gold-standard di validità esterna. 56 soggetti presentavano lesioni patologiche (gruppo di studio) (56,6%), mentre i restanti 43 una morfologia nei limiti (gruppo di controllo) (43,4%). Sul questionario SVHI-10-IT sono state eseguite prove di dimensionalità, test-retest e validità interna. Le variabili del SVHI-10-IT sono risultate uni-dimensionali e l’α di Cronbach era 0.853 (CI 95% = 0,805-0,892). Valori alti e coerenti alla curva ROC (AUC = 0,93; CI 95% = 0,88-0,98) indicano l’abilità del questionario di distinguere tra soggetti patologici e normali con un valore di cut-off di 12, calcolato basandosi su livelli equilibrati di sensibilità (Se = 83,9%) e specificità (Sp = 86,0%). L’SVHI-10-IT è uno strumento valido e affidabile per valutare il livello di handicap vocale auto-riferito in una popolazione di cantanti. Può essere applicato come strumento rapido di screening, utilizzando 12 come valore di cut-off indicativo di problema vocale.

Autres résumés

Type: Publisher (ita)
Adattamento e validazione in italiano del Singing Voice Handicap Index-10 (SVHI-10-IT).

Identifiants

pubmed: 37099435
doi: 10.14639/0392-100X-N2311
pmc: PMC10132479
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-122

Informations de copyright

Copyright © 2023 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.

Références

Kulak Burun Bogaz Ihtis Derg. 2016;26(1):1-6
pubmed: 26794328
Laryngoscope. 2009 Sep;119(9):1864-9
pubmed: 19572269
Eur Arch Otorhinolaryngol. 2014 Apr;271(4):817-23
pubmed: 23974331
J Voice. 2017 Nov;31(6):722-727
pubmed: 28342677
J Voice. 2020 Jan;34(1):158.e9-158.e16
pubmed: 30236537
Laryngoscope. 2004 Sep;114(9):1549-56
pubmed: 15475780
Ann Otol Rhinol Laryngol. 2007 Jun;116(6):402-6
pubmed: 17672240
J Voice. 2019 Mar;33(2):135-142
pubmed: 29242052
J Voice. 1999 Dec;13(4):557-69
pubmed: 10622521
J Psychosom Res. 2003 May;54(5):483-9
pubmed: 12726906
J Voice. 2019 Jul;33(4):582.e1-582.e4
pubmed: 29731379
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Acta Paediatr. 2007 May;96(5):644-7
pubmed: 17376185
J Voice. 2017 Mar;31(2):250.e1-250.e7
pubmed: 28159457
J Voice. 2020 Mar;34(2):304.e9-304.e15
pubmed: 30529026
J Voice. 2020 Sep;34(5):808.e25-808.e28
pubmed: 31031104
J Voice. 2017 May;31(3):383.e1-383.e4
pubmed: 27666652

Auteurs

Andrea Nacci (A)

ENT Audiology Phoniatric Unit, University of Pisa, Pisa, Italy.

Maria Rosaria Barillari (MR)

Department of Mental and Physical Health and Preventive Medicine, "L. Vanvitelli" University, Naples, Naples, Italy.

Silvia Capobianco (S)

ENT Audiology Phoniatric Unit, University of Pisa, Pisa, Italy.

Bruno Fattori (B)

ENT Audiology Phoniatric Unit, University of Pisa, Pisa, Italy.

Stefano Berrettini (S)

ENT Audiology Phoniatric Unit, University of Pisa, Pisa, Italy.

Alessandro Tonacci (A)

CNR Institute of Clinical Physiology, Pisa, Italy.

Fabrizio Minichilli (F)

CNR Institute of Clinical Physiology, Pisa, Italy.

Luca Bastiani (L)

CNR Institute of Clinical Physiology, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH